Showing results 1 to 2 of 2
Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass Aldonza, Mark Borris D.; Delos Reyes, Roben D.; Kim, Young Seo; Ku, Jayoung; Barsallo, Ana Melisa; Hong, Ji-Young; Lee, Sang Kook; et al, SCIENTIFIC REPORTS, v.11, no.1, pp.8016, 2021-04 |
Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy Kim, B.; Wang, S.; Lee, Ji Min; Jeong, Y.; Ahn, T.; Son, D-S; Park, H. W.; et al, ONCOGENE, v.34, no.9, pp.1083 - 1093, 2015-02 |
Discover